D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$638M |
| 2 |
NVIDIA
NVDA
|
+$461M |
| 3 |
EQT Corp
EQT
|
+$400M |
| 4 |
Citigroup
C
|
+$369M |
| 5 |
CELG
Celgene Corp
CELG
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$694M |
| 2 |
Dell
DELL
|
+$486M |
| 3 |
IBM
IBM
|
+$341M |
| 4 |
Amgen
AMGN
|
+$306M |
| 5 |
Johnson & Johnson
JNJ
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.05% |
| 2 | Healthcare | 10.49% |
| 3 | Consumer Discretionary | 10.21% |
| 4 | Financials | 8.38% |
| 5 | Industrials | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
3301
Amarin Corp
AMRN
$284M
| $179K | ﹤0.01% |
2,972
-1,281
| -30% | -$95.1K |
|
3302
CALL
Smith & Wesson
SWBI
$655M
| $178K | ﹤0.01% |
22,377
| – | – |
|
|
CBIO
3303
Crescent Biopharma
CBIO
$602M
| $177K | ﹤0.01% |
109
-1,416
| -93% | -$2.94M |
|
|
CMO
3304
DELISTED
Capstead Mortgage Corp.
CMO
| $176K | ﹤0.01% |
20,392
+8,787
| +76% | +$76.1K |
|
|
PVG
3305
DELISTED
PRETIUM RESOURCES INC.
PVG
| $175K | ﹤0.01% |
26,248
-63,742
| -71% | -$502K |
|
|
IMOS
3306
ChipMOS TECHNOLOGIES
IMOS
$1.92B
| $172K | ﹤0.01% |
+9,231
| New | +$189K |
|
|
BEL
3307
DELISTED
Belmond Ltd.
BEL
| $172K | ﹤0.01% |
+15,433
| New | +$190K |
|
|
ODP
3308
DELISTED
ODP
ODP
| $170K | ﹤0.01% |
7,905
-53,667
| -87% | -$1.58M |
|
|
NFBK
3309
DELISTED
Northfield Bancorp
NFBK
| $169K | ﹤0.01% |
10,800
-2,384
| -18% | -$39K |
|
3310
Coherus Oncology
CHRS
$217M
| $167K | ﹤0.01% |
15,141
-22,965
| -60% | -$251K |
|
3311
Pixelworks
PXLW
$38.8M
| $166K | ﹤0.01% |
3,581
+285
| +9% | +$18.1K |
|
3312
Nokia
NOK
$50.8B
| $163K | ﹤0.01% |
29,819
-342,643
| -92% | -$1.85M |
|
3313
PennantPark Floating Rate Capital
PFLT
$681M
| $163K | ﹤0.01% |
12,472
-78,734
| -86% | -$1.04M |
|
3314
ImmunityBio
IBRX
$7.44B
| $159K | ﹤0.01% |
40,809
+28,781
| +239% | +$126K |
|
|
ARAV
3315
DELISTED
Aravive, Inc. Common Stock
ARAV
| $158K | ﹤0.01% |
15,986
+9,431
| +144% | +$106K |
|
|
FNSR
3316
CALL
DELISTED
Finisar Corp
FNSR
| $158K | ﹤0.01% |
10,000
| – | – |
|
3317
Ardmore Shipping
ASC
$678M
| $155K | ﹤0.01% |
20,379
-49,302
| -71% | -$374K |
|
|
TACO
3318
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $155K | ﹤0.01% |
14,927
-3,166
| -17% | -$39.2K |
|
|
AAV
3319
DELISTED
Advantage Oil & Gas Ltd
AAV
| $154K | ﹤0.01% |
52,217
-165,500
| -76% | -$535K |
|
3320
Ooma
OOMA
$550M
| $153K | ﹤0.01% |
+14,041
| New | +$156K |
|
3321
Teekay
TK
$975M
| $149K | ﹤0.01% |
18,413
-5,650
| -23% | -$48.8K |
|
3322
Mitek Systems
MITK
$762M
| $147K | ﹤0.01% |
19,917
-152,273
| -88% | -$1.24M |
|
|
GOV
3323
DELISTED
Government Properties Income Trust
GOV
| $146K | ﹤0.01% |
+10,669
| New | +$168K |
|
|
NGD
3324
DELISTED
New Gold Inc
NGD
| $137K | ﹤0.01% |
53,084
-11,011
| -17% | -$30.9K |
|
3325
PhenixFIN
PFX
| $137K | ﹤0.01% |
1,715
-2,258
| -57% | -$207K |
|
Similar funds
D.E. Shaw & Co's Q1 2018 Portfolio in Review
As of Q1 2018, D.E. Shaw & Co held 3,998 positions worth $73.5B, up 1.2% from $72.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co's Q1 2018 filing shows 451 new, 1,293 increased, 1,502 reduced and 554 closed positions. Its largest new stake was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M. The largest sale was Meta Platforms (Facebook), an estimated $694M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2018 buy was GCI Liberty, Inc. Class A Common Stock (DE): 2,434,094 shares worth $129M.
- D.E. Shaw & Co added most to Lowe's Companies in Q1 2018, an estimated $638M increase.
- D.E. Shaw & Co's biggest Q1 2018 reduction was Meta Platforms (Facebook), cutting an estimated $694M.
- D.E. Shaw & Co fully exited Liberty Interactive Corporation Series A Liberty Ventures in Q1 2018, selling an estimated $141M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $73.5B portfolio in Q1 2018.
- D.E. Shaw & Co opened 451 new positions and closed 554 in Q1 2018.
- D.E. Shaw & Co's portfolio value rose 1.2% quarter-over-quarter to $73.5B.
Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.